Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6273)
All Articles published online
|
Publishing Process of This Article
|
Nov 21, 2015 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Waheed Y. Hepatitis C eradication: A long way to go. World J Gastroenterol 2015; 21(43): 12510-12512 [PMID: 26604658 DOI: 10.3748/wjg.v21.i43.12510] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v21/i43/12510.htm |
| Number | Citing Articles |
| 1 |
Linda Henry, Zobair Younossi. Patient-reported and economic outcomes related to sofosbuvir and ledipasvir treatment for chronic hepatitis C. Expert Review of Pharmacoeconomics & Outcomes Research 2016; 16(6): 659 doi: 10.1080/14737167.2016.1244007
|
| 2 |
Ahmed El-Nawawy, Shams Abdel-Fattah Arafa, Adham Ahmed Badeib, Manal A.-M. Antonios. A Pilot Study to Assess Transfusion Transmission of Hepatitis C Virus. Indian Journal of Hematology and Blood Transfusion 2020; 36(4): 745 doi: 10.1007/s12288-020-01265-0
|
| 3 |
Khashayar Hesamizadeh, Heidar Sharafi, Mohammad Saeid Rezaee-Zavareh, Bita Behnava, Seyed Moayed Alavian. Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals. Hepatitis Monthly 2016; 16(4) doi: 10.5812/hepatmon.37089
|
| 4 |
Sobia Manzoor, Umair Akhtar, Sidrah Naseem, Madiha Khalid, Misha Mazhar, Fahed Parvaiz, Saba Khaliq. Ionotropic Purinergic Receptors P2X4 and P2X7: Proviral or Antiviral? An Insight into P2X Receptor Signaling and Hepatitis C Virus Infection. Viral Immunology 2016; 29(7): 401 doi: 10.1089/vim.2016.0008
|
| 5 |
Yvonne Chasser, Arthur Y. Kim, Oliver Freudenreich. Hepatitis C Treatment: Clinical Issues for Psychiatrists in the Post-Interferon Era. Psychosomatics 2017; 58(1): 1 doi: 10.1016/j.psym.2016.09.004
|
| 6 |
Yasir Waheed, Masood Siddiq, Zubia Jamil, Muzammil Hasan Najmi. Hepatitis elimination by 2030: Progress and challenges. World Journal of Gastroenterology 2018; 24(44): 4959-4961 doi: 10.3748/wjg.v24.i44.4959
|
| 7 |
Darnna E. Banks, Yael Bogler, Taft Bhuket, Benny Liu, Robert J. Wong. Significant disparities in risks of diabetes mellitus and metabolic syndrome among chronic hepatitis C virus patients in the U.S.. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2017; 11: S153 doi: 10.1016/j.dsx.2016.12.025
|
| 8 |
Jin Hu, Linlin Ma, Huiqiang Wang, Haiyan Yan, Dajun Zhang, Zhuorong Li, Jiandong Jiang, Yuhuan Li. A novel benzo-heterocyclic amine derivative N30 inhibits influenza virus replication by depression of Inosine-5’-Monophospate Dehydrogenase activity. Virology Journal 2017; 14(1) doi: 10.1186/s12985-017-0724-6
|
| 9 |
Babita Agrawal, Shakti Singh, Nancy Gupta, Wen Li, Satish Vedi, Rakesh Kumar. Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension. International Journal of Molecular Sciences 2017; 18(8): 1626 doi: 10.3390/ijms18081626
|
| 10 |
Ali Talha Khalil, Muhammad Ali, Faouzia Tanveer, Muhammad Ovais, Muhammad Idrees, Zabta Khan Shinwari, James E. Hollenbeck. Emerging Viral Infections in Pakistan: Issues, Concerns, and Future Prospects. Health Security 2017; 15(3): 268 doi: 10.1089/hs.2016.0072
|